Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
February 2016

Drugs for Dementia
Current medications for dementia do little to improve cognition or function.

Two New Long-Acting IM Antipsychotics
Aripiprazole lauroxil (Aristada) and a 3-month formulation of paliperidone palmitate (Invega Trinza) have been approved for the treatment of schizophrenia.

Exercise for Late-Life MDD
In a study of older patients with major depressive disorder, both high- and low-intensity exercise added to antidepressant treatment improved remission rates and time to remission.

In Brief
Offspring of Mothers with Polycystic Ovary Syndrome Have Increased Risk of Autism; Androgen Deprivation Therapy Linked to Increased Risk of Alzheimer Disease

A Drug Combination for Agitation in Dementia
In a multicenter trial, the combination of dextromethorphan and quinidine sulfate (Nuedexta) was statistically superior to placebo as a treatment for agitation in patients with Alzheimer disease.

About the BTP Newsletter

Our subscribers say BTP is…

"Very relevant, practical, and thought-provoking."

"About the only thing left without drug ads...objective and balanced."

"Succinct, readable, clear, timely and relevant!"

"Well written and scientifically sound."

Originating at the Massachusetts General Hospital and Harvard Medical School, Biological Therapies in Psychiatry has been a trusted resource for physicians for over 30 years. Described as "influential" by the Atlantic Monthly, this concise, four-page, monthly newsletter provides up-to-date information about the rapidly expanding field of psychotropic medications and other biological treatments for mental disorders.

From his perspective as an editor, teacher, investigator, and clinician, Alan J. Gelenberg, M.D., reviews the widespread literatures of science and clinical practice. Dr. Gelenberg distills the material most relevant for a busy practitioner and presents it each month with a balance of scientific curiosity, healthy skepticism, and clinical experience.

Dr. Gelenberg is Professor and Interim Chair of Psychiatry at Penn State, Hershey. Since 1987, Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, and he recently chaired the workgroup that revised the American Psychiatric Association's major depressive disorder guidelines. Dr. Gelenberg has been on the faculty of Harvard Medical School, MIT, and the University of Arizona and has written numerous scientific articles and book chapters on mood disorders, depression, and schizophrenia. He is listed in the Best Doctors in America and America's Top Doctors and received the 1997 Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill.

We offer both print and online subscriptions. Our web site provides subscribers with 24-hour access to archives as well as current issues. In addition, Continuing Medical Education credit is available for reading BTP. You can earn up to 12.0 hours in category 1 credit by answering questions in the December issue about topics covered during the year.